Altre lingue Shree Ganesh Remedies Limited

Azioni

SGRL6

INE414Y01015

Mercato chiuso - Bombay S.E. Altri mercati azionari 09:00:39 18/05/2024			Variaz. 5gg	Var. 1 gen.
647,6 ^INR	+1,35%		+8,89%	-5,13%

15/03	Shree Ganesh Remedies Limited annuncia i cambiamenti del Segretario della Società e del Responsabile della Conformità	CI
12/02	Shree Ganesh Remedies Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Shree Ganesh Remedies Begins Trial Run of Plant in Gujarat, India	17/04
Shree Ganesh Remedies Limited Announces Company Secretary and Compliance Officer Changes	15/03
Shree Ganesh Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Shree Ganesh Remedies Limited Announces the Reconstitution of Committees and Resignation of Directors	10/11
Shree Ganesh Remedies Limited Announces Director Appointments	18/09/23
Shree Ganesh Remedies Limited Proposes Final Dividend for Financial Year 2022-23, Payable on 25 September, 2023	28/08/23
Shree Ganesh Remedies Forms New Wholly-Owned Subsidiary in US	25/08/23
Shree Ganesh Remedies Limited Announces Intimation for Incorporation of Wholly Owned Subsidiary Company Named Sgrl Usa Inc in United States	24/08/23
Shree Ganesh Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	31/07/23
Shree Ganesh Remedies Gets License to Manufatcure Drugs, Other Products in Gujarat, India	13/07/23
Shree Ganesh Remedies Limited Receives Receipt of FDA License	12/07/23
Shree Ganesh Remedies Limited Recommends Final Dividend for the Year Ended March 31, 2023	30/05/23
Shree Ganesh Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23
Shree Ganesh Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23
Shree Ganesh Remedies CFO Resigns	18/01/23
Shree Ganesh Remedies Books Higher Net Profit in Fiscal Q3	17/01/23
Shree Ganesh Remedies Appoints CFO	17/01/23
Shree Ganesh Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	16/01/23
Shree Ganesh Remedies Limited Announces Appointment of Parth Kothia as Chief Financial Officer	16/01/23
Shree Ganesh Remedies' CFO Resigns	16/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shree Ganesh Remedies Limited

Azioni

SGRL6

INE414Y01015

Altre lingue

Filtri